P2X7 is a cytotoxic receptor….maybe not: implications for cancer
1Department of Medical Sciences, University of Ferrara, Ferrara, Italy. fdv@unife.it.
Abstract:
The tumor microenvironment is rich in extracellular ATP. This nucleotide affects both cancer and infiltrating immune cell responses by acting at P2 receptors, chiefly P2X7. ATP is then degraded to generate adenosine, a very powerful immunosuppressant. The purinergic hypothesis put forward by Geoff Burnstock prompted innovative investigation in this field and provided the intellectual framework to interpret a myriad of experimental findings. This is a short appraisal of how Geoff's inspiration influenced cancer studies and my own investigation highlighting the key role of the P2X7 receptor.
Insights
Extracellular ATP in tumors impacts cancer and immune cells via P2X7 receptors. Its breakdown to adenosine creates an immunosuppressive environment, a key finding influenced by purinergic research.
Area of Science:
- Immunology
- Cancer Biology
- Pharmacology
Background:
- The tumor microenvironment (TME) contains high levels of extracellular adenosine triphosphate (ATP).
- ATP influences cancer cell behavior and immune cell responses through purinergic receptors, particularly P2X7.
- Adenosine, a potent immunosuppressant, is generated from ATP degradation in the TME.
Purpose of the Study:
- To appraise the influence of Geoff Burnstock's purinergic hypothesis on cancer research.
- To highlight the critical role of the P2X7 receptor in cancer immunity.
- To discuss the author's own research inspired by purinergic signaling.
Main Methods:
- Review of existing literature on purinergic signaling in cancer.
- Analysis of experimental findings related to P2X7 receptor function.
- Personal reflection on research trajectory influenced by purinergic concepts.
Main Results:
- Extracellular ATP and its metabolite adenosine significantly modulate the TME.
- The P2X7 receptor is a key mediator of ATP's effects on cancer and immune cells.
- Purinergic signaling provides a framework for understanding TME complexity.
Conclusions:
- Geoff Burnstock's purinergic hypothesis has been instrumental in advancing cancer research.
- Targeting the P2X7 receptor presents a potential therapeutic strategy in oncology.
- Understanding purinergic pathways is crucial for developing novel cancer immunotherapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Mitogens and the Cell Cycle


